Abstract Background: Pulsed field ablation (PFA) has rapidly emerged as a promising alternative to conventional thermal ablation for atrial fibrillation (AF), offering tissue selectivity and procedural efficiency. However, recent evidence has raised concerns about its cerebral safety profile, particularly regarding silent cerebral lesions (SCLs) and microembolic signals (MES) detected by transcranial Doppler. Content: In light of the study “Comparison of cerebral micro-embolization detected by transcranial doppler examination between radiofrequency ablation and pulsed field ablation for atrial fibrillation,” this editorial discusses the unexpectedly high burden of cerebral MES observed with PFA—especially with certain catheter designs—compared with high-power short-duration radiofrequency ablation. Potential mechanisms include gas microbubble formation, microthrombus generation, and device- or technique-related air entrainment. These findings challenge the assumption that PFA is intrinsically safer with respect to cerebral embolization. Conclusion: While PFA represents a major technological advance in AF ablation, the emerging evidence underscores that not all PFA systems are equal regarding embolic safety. Device engineering, procedural optimization, and systematic neurological monitoring are essential to ensure that the benefits of this novel energy source are not offset by an “invisible” cerebral cost. Vigilance and continued innovation will be critical to secure both efficacy and neurological safety in the next generation of ablation technologies.